Safety and antitumour activity of ODM-201 (BAY-1841788) in castration-resistant, CYP17 inhibitor-naïve prostate cancer : results from extended follow-up of the ARADES Trial

QR-koodi

Safety and antitumour activity of ODM-201 (BAY-1841788) in castration-resistant, CYP17 inhibitor-naïve prostate cancer : results from extended follow-up of the ARADES Trial

https://trepo.tuni.fi/handle/10024/103403

http://www.urn.fi/URN:NBN:fi:uta-201805151693

safety_and_antitumour_activity_2017.pdf (Tampereen yliopisto - Trepo)

Teksti

Fizazi, Karim ; Massard, Christophe ; Bono, Petri ; Kataja, Vesa ; Nicholas, James ; Tammela, Teuvo ; Joensuu, Heikki ; Aspegren, John ; Mustonen, Mika ; Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences ; University of Tampere

2017

Tallennettuna:

Kieli

englanti

ISSN

2405-4569

Henkilökuntanäyttö